Home » Medical Devices » Orthobiologics Market

Orthobiologics Market By Product Type (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis And Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 8212 | Report Format : PDF

Industry Outlook

The global orthobiologics market is expected to reach US$ 8,136.9 million in 2026, with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2026. Orthobiologics refer to biologics and cellular therapies in orthopaedics made of a range of products such as recombinant growth factors, bone void fillers, stem cells, and grafts. Orthobiologics has evolved in the last two decades, resulting in a significant role in modern orthopaedic surgeries and therapies. Extensive knowledge of stem cells and biological growth factors in the healing of musculoskeletal injuries, bone regeneration, and tendon and ligament repair has fueled the use of orthobiologics in a variety of orthopaedic ailments. The various products in orthobiologics include platelet-rich plasma (PRP), stem cells, bone grafts, autologous conditioned serum, and growth factors.

Orthobiologics are becoming more popular in sports medicine due to their low side effects and quick recovery time.PRP has demonstrated promising results in the treatment of tendinopathies in adults and is being used as an aid in other sports injury treatments. Other orthopaedic applications of orthobiologics in sports medicine include ACL rupture treatment and cartilage damage, among others. According to the Centers for Disease Control and Prevention (CDC), more than 3.5 million children below the age of 14 receive medical treatment for sports injuries each year in the U.S. alone. Thus, growing sports injuries are a major driver of the growth of the orthobiologics market. As orthobiologic treatments are in their nascent stage, the treatment cost is higher as compared to traditional invasive therapies. Moreover, lower insurance coverage for orthobiologists would further hinder market growth in developing nations.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Synopsis

Osteoarthritis Prevalence to Drive the Orthobiologics Market

In 2017, osteoarthritis and degenerative arthritis held the largest share in the global orthobiologics market, owing to the rise in the target population suffering from degenerative arthritis, growing public awareness regarding the side effects of continuous oral medications, and the introduction of products with better clinical outcomes in osteoarthritis management. The spinal fusion segment is projected to exhibit the fastest growth rate during the forecast period owing to an increase in the number of spinal fusion surgeries globally. The American Academy of Orthopedic Surgeons (AAOS) suggests that a total of 0.46 million spinal fusion surgeries were performed in the U.S. in 2011. The advent of minimally invasive surgeries has further boosted the successful outcomes of spinal surgeries. The demand for bone grafts and stem cells has soared due to the growing number of orthopaedic procedures, consequently driving the orthobiologics market.

North America was the market leader in the global orthobiologics market.

In 2017, North America held the largest share in the global orthobiologics market due to factors such as developed healthcare facilities, patient awareness towards biologics and minimally invasive surgeries, affordability of expensive therapies, and growing research and development of orthobiologics for various orthopaedic disorders. Moreover, the growing prevalence of obesity and the high population of baby boomers susceptible to orthopaedic degenerative ailments further boost the orthobiologics market. As per the CDC Report 2015, osteoarthritis affects approximately 30 million adults in the U.S. Asia Pacific is projected to grow at the fastest rate owing to the budding biopharmaceutical and medical device companies, government initiatives to develop the healthcare infrastructure, and a flourishing medical tourism industry in countries such as India, Thailand, and Indonesia. A large patient pool and growing geriatric population in Japan and China further boost the demand for orthobiologics.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The orthopaedics market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, application, and geography.

The market is studied in order to understand the current and future market trends in the orthobiologics market. The market is estimated by providing the compounded annual growth rate (CAGR) and a data forecast from 2018 to 2026. Strategic mergers, acquisitions, and collaboration among the key players for developing an innovative product pipeline are mentioned in the business strategy section. The key players currently engaged in the orthobiologics market are DePuy Synthes, Stryker Corporation, Medtronic plc, NuVasive Inc., Zimmer Biomet, Globus Medical, Inc., Orthofix International NV, Harvest Technologies Corporation, Seaspine Holdings Corporation, and RTI Surgicals, among others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • How will the global orthobiologics market perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the orthobiologics market and valuable opportunities for key players?
  • Who are the leading players in the global orthobiologics market?
  • Which region leads and grows the most in the global orthobiologics market?
  • Currently, what are the reimbursement scenarios and regulatory structures for orthobiologists?
  • What are the drivers and restraints governing the global orthobiologics market?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Orthobiologics Market Portraiture
2.2. Global Orthobiologics Market, by Product Type, 2017 (US$ Mn)
2.3. Global Orthobiologics Market, by Application, 2017 (US$ Mn)
2.4. Global Orthobiologics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Orthobiologics: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2017

Chapter 4. Global Orthobiologics Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Viscosupplementation Products
4.3. Demineralized Bone Matrices
4.4. Synthetic Orthobiologics
4.5. Bone Morphogenic Protein
4.6. Allografts
4.7. Plasma-Rich Protein
4.8. Bone Marrow Aspirate Concentrate

Chapter 5. Global Orthobiologics Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Osteoarthritis and Degenerative Arthritis
5.3. Spinal Fusion
5.4. Soft-Tissue Injuries
5.5. Fracture Recovery
5.6. Maxillofacial and Dental Applications

Chapter 6. Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Orthobiologics Market Analysis, 2016 – 2026
6.1.1. North America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
6.1.2. North America Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
6.1.3. North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Orthobiologics Market Analysis, 2016 – 2026
6.2.1. Europe Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
6.2.2. Europe Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. Europe Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Orthobiologics Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
6.3.2. Asia Pacific Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Asia Pacific Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America Orthobiologics Market Analysis, 2016 – 2026
6.4.1. Latin America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
6.4.2. Latin America Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Latin America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Orthobiologics Market, 2016 – 2026
6.5.1. Middle East & Africa Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
6.5.2. Middle East & Africa Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Middle East & Africa Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Depuy Synthes (A Subsidiary of Johnson & Johnson)
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Arthrex Inc.
7.3. Bioventus LLC
7.4. Globus Medical Inc.
7.5. Harvest Technologies Corporation (A Terumo Bct Company)
7.6. K2M Group Holdings Inc.
7.7. Kuros Biosciences Ltd.
7.8. Medtronic PLC
7.9. Nuvasive Inc.
7.10. Orthofix International NV
7.11. RTI Surgical Inc.
7.12. Stryker Corporation
7.13. Zimmer Biomet
7.14. Seaspine Holdings Corporation

List of Figures

FIG 1. Orthobiologics Market: Research Methodology
FIG 2. Orthobiologics: Market Segmentation
FIG 3. Global Orthobiologics Market, by Product Type, 2017 (US$ Mn)
FIG 4. Global Orthobiologics Market, by Application Type, 2017 (US$ Mn)
FIG 5. Global Orthobiologics Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2017
FIG 8. Global Viscosupplementation Products Market, 2016-2026 (US$ Mn)
FIG 9. Global Demineralized Bone Matrices Market, 2016-2026(US$ Mn)
FIG 10. Global Synthetic Orthobiologics Market, 2016-2026(US$ Mn)
FIG 11. Global Bone Morphogenic Protein Market, 2016-2026(US$ Mn)
FIG 12. Global Allografts Market, 2016-2026(US$ Mn)
FIG 13. Global Plasma-Rich Protein Market, 2016-2026(US$ Mn)
FIG 14. Global Bone Marrow Aspirate Concentrate Market, 2016-2026(US$ Mn)
FIG 15. Global Orthobiologics Market for Osteoarthritis and Degenerative Arthritis, 2016-2026 (US$ Mn)
FIG 16. Global Orthobiologics Market for Spinal Fusion, 2016-2026(US$ Mn)
FIG 17. Global Orthobiologics Market for Soft-Tissue Injuries, 2016-2026 (US$ Mn)
FIG 18. Global Orthobiologics Market for Fracture Recovery, 2016-2026 (US$ Mn)
FIG 19. Global Orthobiologics Market for Maxillofacial and Dental Applications, 2016-2026 (US$ Mn)
FIG 20. U.S. Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 21. Canada Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 22. U.K. Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 23. Germany Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 24. Rest of Europe Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 25. China Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 26. Japan Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 27. South Korea Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 28. Rest of Asia Pacific Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 29. Brazil Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 30. Mexico Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 31. Rest of Latin America Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 32. GCC Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Middle East & Africa Orthobiologics Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Orthobiologics Market Portraiture
TABLE 2 Global Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Orthobiologics Market, by Application Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Orthobiologics Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Depuy Synthes (A Subsidiary of Johnson & Johnson): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Arthrex Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bioventus LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Globus Medical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Harvest Technologies Corporation (A Terumo Bct Company): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 K2M Group Holdings Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Kuros Biosciences Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Medtronic PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Nuvasive Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Orthofix International NV: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 RTI Surgical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Stryker Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Zimmer Biomet: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Seaspine Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Orthobiologics Market?

The market for Orthobiologics Market is expected to reach US$ 8,136.9 Mn in 2026.

What is the Orthobiologics Market CAGR?

The Orthobiologics Market is expected to see significant CAGR growth over the coming years, at 5.7%.

What is the Forecast period considered for Orthobiologics Market?

The report is forecasted from 2018-2026.

What is the base year considered for Orthobiologics Market?

The base year of this report is 2017.

Who are the major players in this market?

DePuy Synthes, Stryker Corporation, Medtronic plc, NuVasive Inc., Zimmer Biomet, Globus Medical, Inc., Orthofix International NV, Harvest Technologies Corporation, Seaspine Holdings Corporation, and RTI Surgicals are some of the major players in the global market.

Europe Medical Device Contract Manufacturing Market

Published:
Report ID: 40558

Asia Pacific Medical Device Contract Manufacturing Market

Published:
Report ID: 40560

Cell Cytometry Market

Published:
Report ID: 40595

Medical Device Contract Manufacturing Market

Published:
Report ID: 40451

Particle Therapy Market

Published:
Report ID: 39662

Nebulizer Market

Published:
Report ID: 5926

India Medical Lasers Market

Published:
Report ID: 39267

Oncology Information System Market

Published:
Report ID: 39272

Neurostimulation Devices Market

Published:
Report ID: 14447

Manual Resuscitators Market

Published:
Report ID: 38693

Orthopedic Splints and Casts Market

Published:
Report ID: 18021

Vietnam Medical Laser Market

Published:
Report ID: 38377

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN